SEC EDGARAug 24$CHE

LEE SPENCER S sold $541K of CHE

LEE SPENCER S (executive vice president) sold 1,000 shares of CHEMED CORP (CHE) at $541.04 ($0.54M total) on 2026-08-21.

Original reporting

SEC EDGAR · LEE SPENCER S

Published Aug 24, 2026, 1:56 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 24, 2026, 1:58 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$CHE

Bearish

medium confidence

Mentioned

$CHE

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$CHEBearishLow

Why it matters

A $541k sale by a senior executive may prompt short-term traders to consider selling pressure.

Market read

The filing is a primary disclosure of an insider sale, offering modest trading relevance.

What to watch

No 10b5-1 plan; the sale was not pre-arranged, suggesting discretionary action.

Relevance 5/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions and are used by traders to gauge insider sentiment.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CHEBearishMedium confidence

Context

Executive vice president Lee Spencer S sold 1,000 shares for $541,040, a primary Form 4 disclosure.

Expected impact

Potential short-term downward pressure on CHE stock.

Evidence & confidence

Insider sales, especially by senior officers, often signal lack of confidence and can trigger sell-offs.

Market effects

Sector

Minimal impact on the healthcare services sector.

Regional

Limited to US markets where CHE trades.

Global

Low

Counterpoint

What could challenge this read

The sale may be unrelated to company outlook; could be personal liquidity need.

Key entities

Company
Chemed Corp
Provider of health care services and insurance.
Insider
Lee Spencer S
Executive Vice President of Chemed Corp.

Read at source ← All news

$CHEMedAI 9/10

Chemed 3Q 2026: Revenue $690.9M, EPS $5.45— 10-Q Summary

Chemed reported Q3 2026 revenue of $690.9M, up 10.6% YoY, with net income rising 11.5% to $71.6M and EPS increasing 22.2% to $5.45. Growth in VITAS and Roto-Rooter segments drove results, while higher fuel costs pressured margins. The company acquired RotoCo and other franchises, expanding its territories.

tradingview.comOct 29

$CHEMed

What Chemed (CHE) Said on Its Q3 Earnings Call

Chemed reported Q3 earnings, with Roto-Rooter revenue up 7.5% but EBITDA down 2.5% due to higher costs. Commercial revenue grew 9% to $59.9M, while residential rose 5.2% to $158.8M. The company acquired California franchises for $62.5M, expecting $30M-$35M in 2027 revenue but less than $4M in EBITDA. Chemed repurchased 125,000 shares for $66M. Management expects 2026 EPS to meet or slightly exceed guidance.

finance.yahoo.comOct 29

$CHEHigh

Chemed Corp (CHE) Q3 2026 Earnings Call Highlights: VITAS Strength Drives 28% EPS Growth

Chemed Corp (CHE) reported Q3 2026 earnings with VITAS driving 28% EPS growth. Roto-Rooter saw a 2.5% EBITDA decline due to higher marketing and fuel costs. VITAS faces regulatory audits, reviewing $12-$14M in revenue. Chemed anticipates continued cost headwinds in Q4. Management discussed hiring, acquisitions, and lead generation strategies.

finance.yahoo.comOct 28

$CHEMed

Chemed outlines 12- to 18-month integration timeline for $62.5M California Roto-Rooter franchise buyback while expecting 2026 EPS at or slightly above prior high end (NYSE:CHE)

Chemed (CHE) announced a 12- to 18-month integration timeline for its $62.5M California Roto-Rooter franchise buyback. CEO Kevin McNamara reported VITAS revenue grew 12.2% year-over-year, driven by ADC growth and cost containment. The company expects 2026 EPS to be at or slightly above the prior high end.

seekingalpha.comOct 28

$CHEHighAI 8/10

Chemed (CHE) Q3 2026 Earnings Call Transcript

Chemed (CHE) reported Q3 2026 earnings with total revenue up 10.6% and adjusted EPS up 28.1% YoY. VITAS saw 12.2% revenue growth, while Roto Rooter grew 7.5%. Roto Rooter's margins declined due to higher marketing costs and fuel expenses, but acquisitions are expected to drive long-term growth. The company has $229M in cash flow from operations, enabling strategic acquisitions and share repurchases.